News
March 19, 2019
Toronto, March 19, 2019 – The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on Federal Budget 2019.
March 6, 2019
Toronto, March 6, 2019 – The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the Interim report from the Advisory Council on the Implementation of National Pharmacare.
October 17, 2016
Toronto, October 17, 2016 – Greater regulatory convergence is needed to ensure a consistent supply of safe, effective and high-quality generic medicines in Canada, according to a new study prepared by Deloitte LLP and commissioned by the Canada Generic Pharmaceutical Association (CGPA).